Advertisement
Screener

ROIVANT SCIENCES LTD. (ROIV) Deferred Tax Assets, Operating Loss Carryforwards

ROIVANT SCIENCES LTD. Deferred Tax Assets, Operating Loss Carryforwards

ROIVANT SCIENCES LTD. (ROIV) had Deferred Tax Assets, Operating Loss Carryforwards of $550.01 million as of 2026-03-31, per its 10-K filed 2026-05-20.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-05-20

  • 2026-03-31: Deferred Tax Assets, Operating Loss Carryforwards $550.01M.
  • 2025-03-31: Deferred Tax Assets, Operating Loss Carryforwards $469.34M.
  • 2024-03-31: Deferred Tax Assets, Operating Loss Carryforwards $359.97M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $519.05M.
  • 2023-03-31: Deferred Tax Assets, Operating Loss Carryforwards $422.61M.
Period endDeferred Tax Assets, Operating Loss CarryforwardsDeferred Tax Assets, Operating Loss Carryforwards as first filed
2026-03-31$550.01M
10-K · filed 2026-05-20
2025-03-31$469.34M
10-K · filed 2026-05-20
2024-03-31$359.97M
10-K · filed 2025-05-29
$519.05M
10-K · filed 2024-05-30
2023-03-31$422.61M
10-K · filed 2024-05-30
2022-03-31$312.75M
10-K · filed 2023-06-28
2021-03-31$202.91M
10-K · filed 2022-06-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
INSMED Inc (INSM)United States$26.566B-26.60
Zoetis Inc. (ZTS)United States$29.045B11.38
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10